Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
Heart Failure
Diastolic function
Heart failure
Stroke Volume
Preserved ejection fraction
Risk Assessment
Risk prediction
[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
3. Good health
diastolic
03 medical and health sciences
Cardiovascular diseases
0302 clinical medicine
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Echocardiography
RC666-701
Original Research Articles
Diseases of the circulatory (Cardiovascular) system
Humans
Prospective Studies
Heart failure, diastolic
Biomarkers
Cardiac oedema
DOI:
10.1002/ehf2.13251
Publication Date:
2021-03-03T13:45:05Z
AUTHORS (14)
ABSTRACT
Abstract Aims Echocardiographic predictors of outcomes in heart failure with preserved ejection fraction (HFpEF) have not been systematically or independently validated. We aimed at identifying echocardiographic cardiovascular events a large cohort patients HFpEF and to validate these an independent cohort. Methods results assessed the association between parameters 515 left ventricular (LV) (>50%) MEtabolic Road DIAstolic Heart Failure (MEDIA) multicentre study. validated out findings 286 from Karolinska‐Rennes Prospective Study (KaRen). After multiple adjustments including N‐terminal pro‐brain natriuretic peptide (NT‐proBNP), significant death hospitalization were pulmonary arterial systolic pressure > 40 mmHg, respiratory variation inferior vena cava diameter 0.5, E/e' 9, lateral mitral annular s' < 7 cm/s. The combination four variables differentiated <10% vs. >35% 1 year risk. Adding on top clinical NT‐proBNP yielded net reclassification improvement (33.8%, P 0.0001) increase C‐index (5.3%, change 72.2% 77.5%, = 0.015) similar magnitude as addition alone. In KaRen cohort, (22.3%, 0.014) (4.0%, 0.029). Conclusions Use simple (within MEDIA echo score), indicative hypertension, elevated central venous pressure, LV diastolic dysfunction, long‐axis predicted prognosis improved risk stratification additionally HFpEF. This finding was
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....